In addition, this study revealed that murine caspase-11 acquired the ability to cleave pro-IL-18 after replacing its L4 with the corresponding amino acid from caspase-4, which suggests that L4 of caspase-4 may serve as a potential drug target for developing effective treatment strategies against IL-18-related autoimmune diseases. This evidence concerns the gene IL18 and autoimmune disease.